The issue with BKW is actually probably more market perception. A lot of the day to day punters see it purely as the building products business and their guidance in that area was patchy at the recent result. Realistically building products could have a poor couple of years and BKW as a whole might still do really well and grow dividends of the back of SOL and their Industrial Property (which in my opinion is probably the best part of BKW). I see it as a great way to get access to excellent commercial property while still receiving franked dividends which you don't get with a similar REIT like Goodman). I suppose it comes down to the old debate as to whether they are actually reducing the value of the company by having it all merged together. BKW is now going to come back under pressure over their structure having been given a bit of breathing space after the Perpetual Court ruling.
- Forums
- ASX - By Stock
- SOL
- How much higher can we go?
SOL
washington h soul pattinson & company limited
Add to My Watchlist
0.22%
!
$41.69

How much higher can we go?, page-36
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$41.69 |
Change
-0.090(0.22%) |
Mkt cap ! $15.33B |
Open | High | Low | Value | Volume |
$41.90 | $42.18 | $41.69 | $21.69M | 518.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2879 | $41.67 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$41.96 | 2092 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 24 | 41.600 |
1 | 300 | 41.280 |
1 | 13 | 41.050 |
1 | 100 | 41.010 |
5 | 733 | 41.000 |
Price($) | Vol. | No. |
---|---|---|
42.000 | 153 | 1 |
42.190 | 260 | 2 |
42.400 | 800 | 2 |
42.420 | 29 | 2 |
42.500 | 388 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
SOL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online